Cardiology Perspective

 
 
  • A Tribute to Bernard Lown There are lessons for us all in the life and legacy of the renowned cardiologist and peace activist Bernard Lown, notes John Mandrola, MD.
  • Is Red Meat Bad for Your Heart?   Drs Kopecky and Lopez-Jimenez discuss the research on health effects of eating processed and unprocessed meat in the wake of a controversial guideline.
  • FDA Provides the Latest COVID Updates   WebMD Chief Medical Officer John Whyte talks with Dr Janet Woodcock about the latest COVID-19 updates from the US Food and Drug Administration.
  • What the NBA's Collaboration With Yale Reveals About COVID   The NBA was looking for help with COVID-19 surveillance. They found it in Nathan Grubaugh's team at Yale. Grubaugh talks with Eric Topol and Abraham Verghese about that collaboration and more.
  • Move to Single-Dose COVID Vaccine Is Worth a Shot   Switching to a single-dose COVID vaccine program is a reasonable option while vaccine supply is limited, says F. Perry Wilson. Here's a look at the data.
  • Fired for Good Judgment a Sign of Physicians' Lost Respect The firing of a physician who made use of soon-to-expire COVID vaccine doses rather than flush them epitomizes the loss of physician autonomy and respect, warns Melissa Walton-Shirley.
  • Is Taking BP Meds at Night Really Better?   A controversial trial suggests that chronotherapy is key for hypertension management; cardiologist Christopher Labos takes a closer look.
  • What Is #NephMadness and How Do I Play? Forget basketball -- March 1 marks #NephMadness. The annual battle of the brackets is a fun way to learn about hot nephrology topics. Timothy Yau, MD, from the AJKD blog gives the inside scoop.
  • 'Living Brain Implants' May Restore Stroke Mobility A conversation with Dr Mijail Serruya, the principal investigator behind an enticing proof-of-concept study that offers a possible technological solution to improve poststroke mobility.
  • Feb 19 2021 This Week in Cardiology   Bernard Lown, Type 2 MI, Sacubitril/Valsartan and COVID19 anticoagulation are discussed in this week’s podcast.
  • Eye Redness and Rash -- Could It Be Kawasaki?   The Cribsiders share their favorite pearls on Kawasaki disease in kids.
  • Medscape Cardiologist Lifestyle, Happiness & Burnout Report 2021 Medscape surveyed cardiologists about their lives before and during the COVID-19 pandemic, including how burnout and depression have affected their relationships, career, and happiness.
  • Here's the COVID Exit Door -- Will We Walk Through It?   WebMD Chief Medical Officer John Whyte talks with Dr Yaneer Bar-Yam about a COVID-19 elimination strategy that would require a strict 5-week lockdown to create no-virus areas.
  • Giant Leap for Cardiopulmonary Exercise Testing Interpretation Dr Aaron Holley reviews the new cardiopulmonary exercise testing reference equations recently published in CHEST.
  • 'The Impact of the Vaccine Has Been Tremendous'   After a weak early response to COVID, Israel leads the world in vaccinations. The benefits are apparent, Eran Segal says. But hurdles remain, including finishing vaccinations and staving off variants.
  • COVID-19 Has Wiped Out Cancer Research Fundraising   'The impact on fundamental translational clinical research will be enormous and will echo forward for many years,' Dr Kerr laments.
  • Do Zinc and Vitamin C Reduce COVID Symptoms?   A randomized trial looked at the ability of zinc and vitamin C to shorten symptoms of COVID-19 in outpatients. Dr F. Perry Wilson breaks down the data.
  • The Impact of Pandemic Burnout on Physicians   WebMD Chief Medical Officer John Whyte talks with Dr Peter Yellowlees about physician burnout during the pandemic and how doctors can better cope.
  • Feb 12 2021 This Week in Cardiology   Prediabetes, AI and ECGs, HFpEF, and observational studies are the topics discussed by John Mandrola, MD in this week’s podcast.
  • Colchicine Post-MI: Close but No Cigar The inflammatory hypothesis of coronary artery disease has gained traction, but prescribing drugs with anti-inflammatory effects has yet to take off. Could recent data on colchicine change that?